Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 22 March 1985:
Vol. 227. no. 4693, pp. 1490 - 1492
DOI: 10.1126/science.2983428
Prev | Table of Contents | Next

Articles

Science, Vol 227, Issue 4693, 1490-1492
Copyright © 1985 by American Association for the Advancement of Science

articles

Protection from genital herpes simplex virus type 2 infection by vaccination with cloned type 1 glycoprotein D

PW Berman, T Gregory, D Crase, and LA Lasky

Guinea pigs were vaccinated with truncated herpes simplex virus type-1 (HSV-1) glycoprotein D produced in the genetically engineered mammalian cell line gD10.2. Vaccinated animals formed antibodies that neutralized both HSV-1 and herpes simplex virus type 2 (HSV-2) in an in vitro neutralization assay. Vaccinated animals were challenged with HSV-2 by intravaginal infection. Animals that received the immunogen in Freund's complete adjuvant were completely protected from the clinical manifestations of genital HSV-2 infection. Animals that received the immunogen incorporated in alum adjuvants were partly protected from clinical disease; the infections that did develop were significantly less severe than those that occurred in control animals injected with adjuvant alone. The results demonstrate that immunization with a purified viral protein can provide significant protection against primary genital infection by HSV-2 in guinea pigs.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Protective immunity against lethal HSV-1 challenge in mice by nucleic acid-based immunisation with herpes simplex virus type-1 genes specifying glycoproteins gB and gD.
A. BAGHIAN, V. N. CHOULJENKO, O. D'AUVERGNE, M. J. NEWMAN, S. BAGHIAN, and K. G. KOUSOULAS (2002)
J. Med. Microbiol. 51, 350-357
   Abstract »    Full Text »    PDF »
Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide.
J. Harouse, S Bhat, S. Spitalnik, M Laughlin, K Stefano, D. Silberberg, and F Gonzalez-Scarano (1991)
Science 253, 320-323
   Abstract »    PDF »
HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists.
E. Dreyer, P. Kaiser, J. Offermann, and S. Lipton (1990)
Science 248, 364-367
   Abstract »    PDF »
Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein.
L. Lasky, J. Groopman, C. Fennie, P. Benz, D. Capon, D. Dowbenko, G. Nakamura, W. Nunes, M. Renz, and P. Berman (1986)
Science 233, 209-212
   Abstract »    PDF »
Large-scale cell culture in biotechnology.
W. Arathoon and Birch JR (1986)
Science 232, 1390-1395
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)